Human and mouse Abelson interacting proteins (Abi) are SH3-domain containing proteins that bind to the prolinerich motifs of the Abelson protein tyrosine kinase. We report a new member of this gene family, a Drosophila Abi (dAbi) that is a substrate for Abl kinase and that coimmunoprecipitates with Abl if the Abi SH3 domain is intact. We have identi®ed a new function for both dAbi and human Abi-2 (hAbi-2). Both proteins activate the kinase activity of Abl as assayed by phosphorylation of the Drosophila Enabled (Ena) protein. Removal of the dAbi SH3 domain eliminates dAbi's activation of Abl kinase activity. dAbi is an unstable protein in cells and is present at low steady state levels but its protein level is increased coincident with phosphorylation by Abl kinase. Expression of the antisense strand of dAbi reduces dAbi protein levels and abolishes activation of Abl kinase activity. Modulation of Abi protein levels may be an important mechanism for regulating the level of Abl kinase activity in the cell.
Introduction
Many critical cellular functions, such as cell growth and dierentiation, are regulated by the kinase activity of protein tyrosine kinases (PTKs) and deregulated kinase activity of PTKs is associated with oncogenic activity (reviewed by Lavin et al., 1996) . Relatively little is known about the normal regulation of the kinase activity of the Abelson (Abl) non-receptor PTK. Regulation of Abl activity is important (Mayer and Baltimore, 1994) as suggested by the consequences of improper regulation. Oncogenic forms of Abl such as BcrAbl in chronic myelogenous leukemia (CML) and v-Abl in Abelson murine leukemia virus have increased, unregulated kinase activity that phosphorylate several cellular substrates. This increased phosphorylation is believed to activate signal transduction pathways that participate in the uncontrolled cell growth of the tumor cells (Go et al., 1980; Pendergast et al., 1991) . Mutation of the SH3 domain of c-Abl also activates the oncogenic potential of Abl, producing elevated kinase activity, predominantly cytoplasmic localization, and cell transformation (reviewed by Feller et al., 1994) . It has been proposed that the SH3 domain of c-Abl may have a function in the negative regulation of Abl's activity (Mayer and Baltimore, 1994; Wang, 1993) . Overexpression of c-Abl in cells results in autophosphorylation of c-Abl, suggesting that there might be a limited concentration of a cellular modulator that suppresses c-Abl activity in cells (Pendergast et al., 1991) . Thus, one of the models which has been proposed for the inhibition of the cAbl tyrosine kinase invokes a trans-acting cellular inhibitor interacting with the Abl SH3 domain (Mayer and Baltimore, 1994) .
Proteins that interact with the SH3 domain of Abl and that might thereby modulate kinase activity of Abl have recently been identi®ed. Initial reports identi®ed three mammalian Abi proteins; murine Abi-1, hAbi-2 and human ArgBP1 (Dai and Pendergast, 1995; Shi et al., 1995; Wang et al., 1996) . The Abi proteins physically associate with Abl and Abelson-related (Arg) kinases. The sequence motifs of Abi family members include an SH3 domain, proline-rich regions, PEST regions, and a homeodomain homologous region (Dai and Pendergast, 1995; Shi et al., 1995) . Abi proteins are phosphorylated by the Abl PTKs. Overexpressing full length mouse Abi-1 in NIH3T3 cells suppresses v-Abl transforming activity (Shi et al., 1995) . Stable expression of the full length hAbi-2 is toxic in NIH3T3 cells, but expression of a truncated form of hAbi-2, which lacks the ®rst 157 amino acids including a proline-rich domain required for binding the Abl-SH3 domain, activates c-Abl transforming activity in NIH3T3 cells (Dai and Pendergast, 1995) . It was proposed (Dai and Pendergast, 1995; Shi et al., 1995) that Abi is a tumor suppressor in mammalian cells. Hypothesized regulatory functions of Abi include stabilization of the inactive form of c-Abl or, alternatively, inhibiting access of Abl to protein substrates and thereby negatively regulating Abl activity.
The Abl gene has been conserved through evolution and related genes have been found in human, cat, mouse, Drosophila and C. elegans (Homann, 1991) . We have used Drosophila genetics to understand the regulatory molecules of the conserved Abl pathway. In order to determine if Abi regulation of Abl is a mechanism that has been conserved through evolution, we attempted to isolate a Drosophila member of the Abi family. We report the identi®cation of dAbi. Analysis of the dAbi protein shows very similar structural features to that of mammalian proteins. dAbi behaves similarly to mammalian Abi proteins by associating with Abl kinase and serving as a substrate for the Abl kinase. We report on two new properties revealed by our biochemical analysis of both dAbi and hAbi-2 proteins. First, dAbi and hAbi-2 act as potent activators of Abl kinase activity. Second, dAbi is an unstable protein that is stabilized coincident with phosphorylation. We propose that regulation of Abi protein levels may be a mechanism for modulating Abl kinase activity that has been well conserved during evolution.
Results

Molecular cloning of dAbi
Degenerate oligonucleotides were designed based on the conserved SH3 domain peptide sequences of mammalian Abi proteins and used for PCR of Figure 1 Sequence and structure of dAbi. (a) Alignment of the predicted amino acid sequences of dAbi with: human e3B1, an eps8 binding protein (AF006516), and hssh3bp1, human spectrin SH3 binding protein 1 (U87166) (Biesova et al., 1997) ; ZiemnickaKotula et al., 1998); hAbi-2 (U23435), (Dai and Pendergast, 1995) ; human ArgBP1A (X95632), ; human Abl binding protein 3 (U31089); murine Abi-1 (U17698), (Shi et al., 1995) ; Xenopus 35K proline-rich protein Xlan4 (M94969), (Reddy et al., 1992) ; rat thyroid hormone responsive protein, THRP, (U94904), (Shah et al., 1997) and C. Elegans last exon similar to SH3 domain (U32305). Arg BP1 and hAbi-2 are thought to represent the product of the same gene . Human e3B1, an eps8 SH3 domain-binding protein is reported to be identical to isoform 2 of human spectrin SH3-binding protein, hssh3bp1 (Ziemnicka-Kotula et al., 1998) . Bold print is used where identical amino acids or conservative substitutions are present in both dAbi and four or more of the other sequences. Borken overlines indicate three proline rich regions. The homeo domain homologous region at the amino terminus and the SH3 domain at the most carboxyl terminus are indicated by solid overlines. (b) Schematic structure of dAbi Drosophila embryonic cDNA libraries. A fragment of 146 bp, the expected size of the SH3 domain, was isolated, cloned and sequenced. The predicted open reading frame was most similar in sequence to the mammalian Abi SH3 domain. The DNA fragment was used as a probe for high stringency screening of the library and hybridized to a 1.7 Kb Drosophila cDNA. The cDNA encodes a predicted open reading frame of 473 amino acids. A BLAST search of the GenBank non-redundant peptide sequence database (nr) identi®ed a number of Abi and Abi-related proteins. dAbi appeared most similar to human e3B1/hssh3bp1, sharing 42% amino acid sequence identity and 54% amino acid similarity (Biesova et al., 1997; ZiemnickaKotula et al., 1998) (Figure 1a ). Human e3B1 was originally identi®ed in a screen for proteins that bound the SH3 domain of eps8, a substrate of receptor tyrosine kinases including the epidermal growth factor receptor (EGFR) tyrosine kinase (Biesova et al., 1997) . In vitro assays with GST fusion proteins showed that e3B1 also bound the SH3 domain Abl (Biesova et al., 1997) . Subsequently, one isoform of a candidate spectrin SH3 domain-binding protein was found to be identical to e3B1 (Ziemnicka-Kotula et al., 1981) . The Drosophila sequence shows similar levels of amino acid identity when compared to other human Abi proteins. Pairwise sequence comparisons showed 40% amino-acid identity and 54% amino-acid similarity between dAbi and human ArgBP1A whereas comparison of dAbi and hAbi-2 gave similar results showing 39% amino-acid identity and 52% amino-acid similarity. The Drosophila sequence has motifs similar to those found in the human Abi proteins including a carboxy-terminal SH3 domain with 76% identity to hAbi-2. The amino-terminal domain includes a homeodomain similarity, and the middle portion includes three polyproline motifs and a PEST domain ( Figure  1b ). We propose that this sequence be called Drosophila Abi (dAbi).
dAbi is phosphorylated by Abl PTK
In mammalian cells, Abi is phosphorylated by the Abl kinase (Dai and Pendergast, 1995; Shi et al., 1995) . To determine whether dAbi was phosphorylated, we coexpressed several non receptor PTKs with dAbi in Drosophila S2 cells. Western blots of dAbi immunoprecipitates from cell lysates detected a band that migrated with the expected size of 52 kDa (Figure 2b , lane 1). DAbi immunoprecipitates from transfected cells were immunoblotted with anti-phosphotyrosine antibody. dAbi was phosphorylated when coexpressed with Drosophila Abl (dAbl), human BcrAbl, or human c-Abl in S2 cells (Figure 2a , lanes 3, 5 and 7). However Drosophila Src (dSrc) or Fer (dFer) were unable to phosphorylate dAbi (Figure 2a, lanes 9 and 11) . The same ®lter was reprobed with anti-Abi antibody to show that dAbi was expressed in all samples ( Figure  2b ). These data suggest that dAbi is phosphorylated by Abl PTKs.
Tyrosine-phosphorylation increases dAbi protein levels
The anti-Abi signal intensity on Western blots was reproducibly increased when Abi was coexpressed with dAbl, BcrAbl, or c-Abl (Figure 2b, lanes 3, 5, and 7) suggesting that the phosphorylated form of dAbi was present at a higher level than the unphosphorylated form. The possibility that the elevated dAbi protein level may be associated with the phosphorylation of dAbi was further investigated by cotransfecting dAbi with a kinase defective Abl (Henkemeyer et al., 1990) These results suggest that dAbi protein levels are coincident with Abl kinase activity.
We have used transient overexpression of several proteins in our studies on Abl and Ena but in contrast to our experiences with these other proteins, the protein level of dAbi was not elevated signi®cantly by transient overexpression in S2 cells (compare lanes 1 to 2, 8 to 9, or 10 to 11 in Figure 2b ). To determine whether dAbi is subject to rapid protein turnover, pulse-chase experiments were conducted using metabolically labeled S2 cells (see Materials and methods). In comparison to Ena (Figure 3e ), dAbi is an unstable protein ( Figure 3d ) with a half-life of about 107 min.
The dAbi SH3 domain is critical for binding to Abl
The mammalian Abi proteins have been reported to physically interact with the Abelson tyrosine kinase. Thus, we tested whether dAbi could also interact with Figure 2 dAbi is phosphorylated by Abl PTKs. Drosophila S2 cells were transfected with expression vectors for Abi (Lanes 1, 3, 5, 7, 9 and 11) and expression vectors for dAbl (lanes 2 and 3), BcrAbl (lanes 4, 5), human cAbl (lanes 6, 7), d Src (lanes 8, 9) or dFer (lanes 10 and 11). (a) In vivo phosphorylation of dAbi. Cell lysates were immunoprecipitated with anti-Abi and immunoblotted with anti-phosphotyrosine monoclonal antibody 4G10. dAbi was tyrosine phosphorylated when coexpressed with dAbl (lane 3), BcrAbl (lane 5), or cAbl (lane 7) but was not detectably phosphorylated by dScrc or dFer. (b) dAbi immunoprecipitates were probed with anti-dAbi antibody. The dAbi protein level was increased when dAbi was cotransfected with Abl PTKs (lanes 3, 5 and 7). Phosphorylation also resulted in a slower migrating protein band detectable by anti-Abi in lanes 3, 5 and 7). Both bands were detected with anti-phosphotyrosine (a) although the slower migrating band had a stronger signal and presumably more phosphotyrosine Abl. When dAbi and Abl were coexpressed in S2 cells, Abl was coimmunoprecipitated with the full length dAbi by dAbi antibody (Figure 4a , lane 4). Previously it was found that the SH3 domain of both hAbi-2 and murine Abi-2 was essential for binding these proteins to Abl (Dai and Pendergast, 1995; Shi et al., 1995) . Similarly, we found that Abl could not coimmunoprecipitate with dAbi if its SH3 domain was deleted (Figure 4a , lane 5). The immunoprecipitates from transfected cells were probed with anti-dAbi to show that ccomparable levels of dAbi and dAbiDSH3 proteins were expressed in all samples (Figure 4b ). These data suggest that the dAbi SH3 domain is critical for binding to Abl in vivo.
Abi proteins activate Abl PTK kinase activity
Mammalian Abi-1 and Abi-2 were originally identi®ed as protein modulators of c-Abl or v-Abl transforming activity that negatively regulate Abl kinase activity (Dai and Pendergast, 1995; Shi et al., 1995) . To examine whether dAbi modulates the kinase activity of Abl PTK in vivo, we used phosphorylation of the Drosophila Enabled (Ena) protein, a known substrate of the Abl tyrosine kinase, as an assay of Abl kinase activity. We tested dAbl, BcrAbl (as a constitutively active Abl tyrosine kinase), and human c-Abl, which phosphorylates Ena poorly in S2 cells. Whole cell lysates from cells transfected with Ena and each of the kinases were immunoblotted with anti-phosphotyrosine antibody to detect phosphotyrosine signal. In the presence of dAbi, Ena was phosphorylated by dAbl, BcrAbl, or c-Abl (Figure 5a , lanes 4, 6 and 8). The identity of the phosphorylated protein was con®rmed by Western blotting cell lysates with anti-Ena (data not shown). Co-expression of c-Abl and Ena resulted in only low levels of Ena phosphorylation in transfected cells (Figure 5a, lane 7) . However, in the presence of dAbi, c-Abl autophosphorylation and Ena phosphorylation by c-Abl were increased (Figure 5a , lane 8). Consistent with our previous reports (Gertler et al., 1995) , the phosphotyrosine content of Ena was increased by coexpression with dAbl in S2 cells (Figure 5a, lane 3) . However, co-expression of dAbi with dAbl signi®cantly elevated its ability to phosphorylate Ena (Figure 5a, lane 4) . BcrAbl constitutively autophosphorylates itself and hyperphosphorylates its cellular substrates (Figure 5a , lane 5). However, there was a detectable increase of Ena phosphorylation when BcrAbl was coexpressed with dAbi ( Figure 5a, lane 6) . Finally, co-expression of dAbi did not lead to increased levels of Ena phosphorylation by dSrc (Figure 5a, lane 10) or dFer (Figure 5a, lane 12) suggesting that dAbi is a speci®c activator of the Abl non-receptor tyrosine kinases.
To determine whether the activation of Abl kinase activity by Abi also occurs in mammalian cells, we conducted the analogous experiment using COS cells. COS cells were co-transfected with human c-Abl, Ena and either dAbi or hAbi-2. Ena immunoprecipitates from transfected cells were probed with anti-phosphotyrosine antibody. Both dAbi and hAbi-2 proteins increased phosphorylation of Ena by c-Abl (Figure 5d , compare lane 5 (no Abi) with lane 6 (dAbi) and lane 7 (hAbi-2)). The same ®lter of Ena immunoprecipitates was reprobed with an anti-Ena antibody, showing comparable levels of Ena were expressed in all samples transfected with Ena ( Figure 5e ). Accordingly, we propose that both hAbi-2 and dAbi act as activators of Abl PTKs.
Abi SH3 domain is critical for activating Abl kinase activity
The ®nding that the dAbi SH3 domain is required for co-immunoprecipitation of dAbi and Abl led us to analyse whether the SH3 domain of dAbi is required for the activation of c-Abl kinse activity in vivo. Either full-length dAbi or dAbiDSH3 was cotransfected with c-Abl and Ena in Drosophila S2 cells. The antiphosphotyrosine immunoblot of cell lysates shows that the anti-phosphotyrosine signals of c-Abl (autophosphorylation), Ena, and dAbi were reduced in cells expressing dAbiDSH3 (Figure 6a, lane 4) . Immunoprecipitation and Western blotting of dAbi (Figure 6b ), cAbl (Figure 6c , and Ena (Figure 6d ) from cell lysates of co-transfected S2 cells shows that loss of phosphotyrosine signal (Figure 6a, lane 4) is not due to loss of protein expression. This data suggests that the SH3 domain of dAbi is required for the activation of c-Abl kinase activity.
Antisense dAbi blocks the activation of Abl PTKs induced by dAbi
A construct designed to express a full length dAbi antisense RNA was used to determine whether the elevated kinase activity of Abl PTKs, as induced by dAbi, could be eliminated by the introduction of antisense dAbi. Cell lysates from cells co-expressing Ena and dAbi with either dAbl, c-Abl, or Bcr-Abl were immunoblotted with anti-phosphotyrosine antibody. Figure 7a (lanes 3, 6 and 9) shows that antisense dAbi dramatically decreased the Ena phosphotyrosine signal to basal levels ( Figure 7a,  lanes 1, 4 and 7) . The same ®lter reprobed with anti-Ena antibody shows that comparable levels of Ena were expressed in all samples transfected with Ena ( Figure 7c ) and that the expression of the antisense dAbi did not aect the protein levels of Ena. In addition, examination of the dAbi protein levels in the same experiment revealed that the abolishment of dAbi activation of Abl coincides with reduced dAbi protein levels (Figure 7b , compare lanes 2 and 3, lanes 5 and 6, and lanes 8 and 9). When immunoprecipitates of dAbi were immunoblotted with anti-dAbi antibody, only endogenous levels of dAbi signal (Figure 7b, lanes 3, 6 and 9) were detected from cells coexpressing the antisense dAbi indicating that dAbi protein levels were reduced by antisense dAbi. 
Discussion
Identi®cation of interacting proteins is a valuable method for de®ning new components of signal transduction pathways in general and has provided several candidate proteins that may be critical regulators or substrates of the Abl PTKs (Feller et al., 1994) . Abi proteins were identi®ed in two hybrid screens using the carboxy-terminal domain of Abl or the SH3 domain of Abl. Abi and Abl can potentially interact at two sites, the SH3 domain of Abl with the proline motifs of Abi and the SH3 domain of Abi with the proline motifs of Abl. In addition to binding to Abl, Abi proteins appear to be excellent substrates for the kinase, raising a question of whether Abi proteins are upstream regulators or downstream eectors of the kinase. Abi-1 has been proposed to be a negative regulator of Abl because its full length protein suppresses v-Abl transformation (Shi et al., 1995) . The full length hAbi-2 was also suggested to function as a potential tumor suppressor gene through negative regulation of Abl kinase activity (Dai and Pendergast, 1995) . One hypothesis put forth to explain Abi's suppression of Abl's transforming activity is that binding of Abi to the Abl SH3 domain negatively regulates Abl kinase (Dai and Pendergast, 1995) . This hypothesis was based in part on observations that structural alterations of Abl that attenuate binding to Abi, e.g. mutation of the Abl SH3, enhance the transforming activity of c-Abl (Franz et al., 1989; Goga et al., 1993; Jackson and Baltimore, 1989; Mayer and Baltimore, 1994; Rosenberg and Witte, 1988) . However, the observation that Abi-1 did not inhibit the overall kinase activity of v-Abl (Shi et al., 1995) suggests that Abi-1 suppression of v-Abl transforming activity may be due to other mechanisms of action.
The identi®cation of a Drosophila Abi protein indicates that the Abl-Abi interaction may have been conserved during evolution. dAbi and hAbi-2 are 39% identical and 52% similar in amino acid sequence and share similar protein motifs. dAbi associates with Abl, as determined by co-immunoprecipitation, and is a Figure 7 Antisense dAbi blocks the activation of Abl PTKs. Drosophila S2 cells were transfected with expression vectors encoding dAbl (lanes 1 ± 3), human c-Abl (lanes 4 ± 6), Bcr-Abl (lanes 7 ± 9), Ena (lanes 1 ± 9), dAbi (lanes 2, 3, 5, 6, 8 and 9) and the antisense orientation of dAbi (lanes 3, 6 and 9). (a) Immunoblots of cell lysates with anti-phosphotyrosine antibody detected an increase in the phosphorylation level at mobilities similar BcrAbl, cAbl, Ena and dAbi as indicated by the arrows to the right of the panel. Lanes 3 and 6 show that the presence of antisense dAbi considerably decreased phosphotyrosine signal at mobilities similar to those of c-Abl (compare lanes 5 and 6) and Ena (compare lanes 2 to 3 and lanes 5 to 6). The presence of the antisense dAbi had a slight eect on Bcr-Abl phosphorylation of Ena (compare lanes 7, 8 and 9) but did eliminate the signal at the mobility of dAbi (compare lanes 8 and 9). (b) Immunoprecipitation and Western analysis of cell lysates with anti-dAbi indicated that the increase in dAbi level after transfection with an dAbi expression vector (lanes 2, 5 and 8) was eliminated by co-transfection with the reverse orientation dAbi expression vector predicted to produce an antisense dAbi mRNA (lanes 3, 6 and 9). (c) The same ®lter from cell lysates reprobed with anti-Ena antibody shows that comparable levels of Ena were expressed in all samples transfected with Ena substrate for the Abl PTK. The dAbi SH3 domain is required for a detectable interaction with the Abl kinase. Surprisingly, transient coexpression of Abl kinase with either dAbi or hAbi-2 proteins in both Drosophila S2 cells and mammalian COS cells leads to activation of Abl kinase that is dependent upon the presence of an intact Abi SH3 domain.
One model to explain how dAbi and hAbi-2 might activate Abl kinase would be that interaction of Abi with Abl generates a conformational change in Abl that results in exposure of its catalytic domain. Data to support this model comes from a recent report on site directed mutations in the Abl catalytic domain, SH3 domain and linker region between the SH2 and catalytic domain (SH2-CD) (Barila and Superti-Furga, 1998) . Mutations in all three domains were found to activate cAbl kinase implicating intramolecular inhibitory interactions of the Abl SH3 domain with the catalytic domain and with the SH2-CD linker region. In addition, mutation of the SH2-CD linker region caused a conformational change in the protein resulting in altered and increased protease sensitivity of the mutated protein compared with c-Abl (Barila and Superti-Furga, 1998 ). Such a model could also reconcile the con¯icting observations that dAbi and hAbi-2 activate Abl kinase activity yet Abi proteins are reported to suppress Abl transforming activity since binding of Abi to Abl may also have a role in regulating other biological activities of Abl such as Abl transforming activity (Dai and Pendergast, 1995; Shi et al., 1995) .
Although the activation of Abl kinase by dAbi implicates dAbi as an upstream regulator of Abl, Abl also has eects on dAbi. Phosphorylation of dAbi leads to a signi®cant increase in the steady state level of dAbi protein. The rapid turnover of dAbi in S2 cells suggests that a potential mechanism for the increase in dAbi level is through a phosphorylation-dependent increase in dAbi protein stability. Although dAbi may have other binding partners than Abl, one possible eect of the increased dAbi protein levels would be to provide an ampli®ed or sustained activation of the Abl kinase. In this role, an increase in dAbi level would result in dAbi binding to Abl, activation of Abl kinase activity, increased phosphorylation of Abl substrates, including dAbi, and an additional increase in dAbi steady state levels that would maintain activation of Abl kinase. Clearly some additional mechanism would be needed to terminate this hypothetical positive regulatory loop.
If dAbi is a key regulator of Abl kinase in vivo, it will be important to understand the regulation of dAbi protein turnover. Proteolysis is critical for controlling protein concentrations in other key processes, such as signal cascades and the cell cycle. Reversible protein phosphorylation has also been linked to the regulation of protein degradation. Phosphorylation of proteins, such as the cyclins, leads to ubiquitination and degradation of proteins (Diehl et al., 1997; Willems et al., 1996) . However, in other proteins, e.g. c-jun, phosphorylation results in a reduction in ubiquitination and stabilization (Musti et al., 1997) . Analyses of dAbi and hAbi-2/ArgBP1 sequences have revealed PEST sequences, regions rich in proline (P), glutamic acid (E), serine (S) and threonine (T). Such sequences have been suggested (Rogers, et al., 1986) to target rapid intracellular degradation of proteins. Many PEST-containing proteins are important regulatory molecules, such as components of signal transduction pathways, homeotic proteins, and key enzymes. Wang et al. (1996) have reported that a human Abi isoform, ArgBP1A, with three PEST regions, has a consistently lower expression level than another isoform, ArgBP1B, with only two PEST regions, consistent with a role of the PEST motifs in Abi protein stability.
Regulation of protein stability is thought to be important in how cells respond to DNA damage. In response to DNA damage, p53 protein turnover is reduced and its level rises (Levine et al., 1994; Perry and Levine, 1993) . The increased p53 levels are important to cause G1 arrest and provide cells an opportunity to repair the DNA damage, or to prevent further proliferation of the damaged cell by causing apoptosis. Regulation of c-Abl has also been implicated in the DNA damage-induced apoptosis. In response to DNA-damaging agents, c-Abl protein tyrosine kinase down-regulates cdk2 and causes G1 arrest by a p53-dependent mechanism and may also be involved in a p53-independent induction of apoptosis (Yuan et al., 1997) . In response to DNA damage, the ataxia telangiectasis mutant (ATM) protein is reported to phosphorylate and activate c-Abl (Baskaran et al., 1996; Fernandes et al., 1996) . It will be interesting to determine whether DNA damage also alters the protein stability of Abi, as this would provide an additional mechanism for activating Abl kinase activity in response to DNA damage.
The Abl kinase has been implicated in cancer, regulation of the cell cycle, regulation of cell adhesion and normal developmental processes in Drosophila and mammalian systems. Further study of Abi proteins may provide new insights into how Abl kinase activity is regulated in one or more of these processes. The identi®cation of a dAbi will also permit genetic analysis of Abi in normal development.
Materials and methods
Cloning of dAbi
An alignment of the conserved SH3 domain peptide sequences of several mammalian Abi proteins was used to design degenerate PCR primers. The upstream primer was 5'-GT(A/C/G/T) GCI (I=inosine) AT(T/C/A) TA(T/C) GA(T/ C) TA(T/C)-3', the reverse complement of the downstream target was 5'-(A/C/G/T)AC (A/G)TA (A/G)TT ICC (A/C/G/ T)GG (A/G)AA-3'. Ampli®cation was performed as follows: 948C 2 min, addition of Taq Polymerase (Promega), followed by 948C 30 s, 478C 45 s, 728C 1 min for 3 cycles, 948C 30 s, 528C 45 s. 728C 2 min for 35 cycles, and a ®nal extension of 728C for 5 min. DNA of the 146-bp product was cloned into pCR2.1 (Invitrogen) prior to sequence determination.
DNA containing this 146 bases of sequence was labeled with a 32 P-dCTP and used for high stringency screens of Drosophila embryo MATCHMAKER cDNA library (Clontech). DNA sequencing was performed on an ABI373. Sequence analysis was performed by the Sequencher 2.1 (Gene Codes Co). The BLAST program on NCBI GenBank databases was used to search for sequence similarity. The multi-alignment of sequences was carried out using ClustalW multi-sequence alignment program (version 1.7). Pairwise sequence alignments were carried out using BLAST 2 (version BLASTP 2.0.6) to determine the per cent amino acid identity and similarity between dAbi and related sequences. (Gertler et al., 1995) . p PAC Bcr/Abl was constructed by using bcr exon 1 and human abl exon 2 plus the ®rst 204 codons of exon 3 fused to Drosophila Abl sequence at a conserved NcoI site (gift of Dr Frances J Fogerty, University of Wisconsin, USA). Full length antisense dAbi was constructed using the NotI-XbaI fragment excised from the pBS Abi and subcloned into p PAC . The SH3 domain deletion of dAbi was constructed using a PCR-directed mutagenesis strategy. The DNA sequence encoding amino acids 292 ± 424 of dAbi was ampli®ed by PCR. The PCR-generated cDNA fragment was digested with SacII and XbaI and subcloned into pPAC-dAbi cut with SacII and XbaI. pPAC-dAbi DSH3, was sequenced twice from both ends of the deleted region to con®rm the SH3 domain deletion. The resulting protein product is referred to as AbiDSH3 and lacks the entire SH3 domain (amino acids 422 ± 473). For mammalian cell protein expression, full-length cDNA of c-Abl and Abi were inserted downstream of the cytomegalovirus (CMV) promoter to form plasmid P PRC c-Abl and P PRC Abi. The P PCGN Abi-2 and P RC ena were gifts of Dr Ann Marie Pendergast (Duke University) and Dr Shawn M AhernDjamali (University of Wisconsin, USA), respectively.
Cell lines and transfections
The Drosophila S2 cell line was maintained in M3 media containing 10% fetal calf serum and transfected using lipofection. COS cells were maintained in DMEM containing 10% fetal bovine serum and were transiently transfected for 48 h with Lipofectamine (Life Technologies).
Pulse-chase experiment
After 3 days incubation in M3 media containing 10% fetal calf serum, cells were harvested and starved in M3 media without L-methionine and L-cystine for 60 min. The cells were metabolically labeled for 2 h with 0.5 mCi of Trans 35 Slabel (ICN Radiochemicals) per 3610 6 cells. Cells were transferred into the normal culture media containing Lcystine and L-methionine for 0.5 h, 1 h, 2 h, and 4 h (chase). At the indicated time points, cells were lysed on ice for 30 min in 1 ml cold lysis buer. Protease inhibitors (100 mM N-acetyl -L -leucinyl -L-leucinyl -methioninal, N-acetyl-L-leucinyl-L-leucinyl-norleucinal, 100 mM ALLN, 1 mM pefabloc, 1 mg/ml pepstatin, 1 mg/ml aprotinin, 1 mg/ml leupeptin) were added into the lysis buer. Cell lysates were subjected to immunoprecipitation with anti-Abi antibody and analysed by SDS ± PAGE. Phosphoimager 425 using IMAGEQUANT software (Molecular Dynamics) was used for quantitative analyses of Abi and Ena. The half-life (t 1/2 ) of Abi protein was calculated by the formula t 1/2 =(0.6936t)/ln (N 1 /N 0 ) (Luscher and Eisenman, 1988) .
Immunoprecipitation and Western blot analysis S2 cells were immunoprecipitated and immunoblotted as described (Gertler et al., 1993) . ECL detection reagent (Amersham) was used to detect the immunoreactive proteins. Anity-puri®ed Abi polyclonal against the peptides CPDGRQSLRDSYTNLER and EDEHQDFGRPRTS-TGPQLC (produced by QCB) were used for immunoprecipitation and immunoblotting.
